Dupilumab Use in Severe Epidermolysis Bullosa Simplex
This case report describes treatment with dupilumab in an infant patient with generalized severe epidermolysis bullosa simplex due to a pathogenic variant.
Authors
- J. Bonigen (ORCID: https://orcid.org/0009-0000-6577-9148)
- N. Bellon (ORCID: https://orcid.org/0000-0003-3311-1674)
- Maria Leite-De-Moraes
- Fabienne Charbit‐Henrion (ORCID: https://orcid.org/0000-0003-4615-3953)
- Orsola Crespi (ORCID: https://orcid.org/0009-0001-9270-1204)
- Christine Bodemer
Institutions
- Hôpital Necker-Enfants Malades (FR)
- Université Paris Cité (FR)
- Institut Necker Enfants Malades (FR)
Publication Details
- Journal
- JAMA Dermatology
- Published
- 2026-02-25
- DOI
- https://doi.org/10.1001/jamadermatol.2025.5754
- Primary Topic
- Skin and Cellular Biology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00